Paradoxical effects of all-trans-retinoic acid on lupus-like disease in the MRL/lpr mouse model

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Liao, Xiaofeng ^a   Ren, Jingjing ^a   Wei, Cheng Hsin ^b   Ross, A Catharine ^b   Cecere, Thomas E ^a   Jortner, Bernard S ^a   Ahmed, S Ansar ^a   Luo, Xin M ^a  

^a VIRGINIA MARYLAND REGIONAL COLLEGE OF VETERINARY MEDICINE   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RETINOIC ACID; RETINOL; AUTACOID;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; DENDRITIC CELL; DERMATITIS; DISEASE SEVERITY; ENCEPHALITIS; FEMALE; HUMORAL IMMUNITY; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; KIDNEY DISEASE; LUPUS LIKE SYNDROME; LYMPHADENOPATHY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN EXPRESSION; ANIMAL; AUTOIMMUNITY; BRAIN; DISEASE MODEL; DRUG EFFECTS; IMMUNOLOGY; KIDNEY; LEUKOCYTE; LUNG; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHATIC DISEASES; MURPHY ROTHS LARGE LYMPHOPROLIFERATIVE MOUSE; PATHOLOGY; SKIN;

MUS;

AGE FACTORS; ANIMALS; AUTOIMMUNITY; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; INFLAMMATION MEDIATORS; KIDNEY; LEUKOCYTES; LUNG; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHATIC DISEASES; MICE; MICE, INBRED MRL LPR; SKIN; TRETINOIN;

EID: 84925251015     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0118176     Document Type: Article

References (75)

1. Chen F, Cao Y, Qian J, Shao F, Niederreither K, Cardoso WV. A retinoic acid-dependent network in the foregut controls formation of the mouse lung primordium. The Journal of clinical investigation. 2010 Jun; 120(6):2040-8. doi: 10.1172/JCI40253 PMID: 20484817
2. Hall JA, Grainger JR, Spencer SP, Belkaid Y. The role of retinoic acid in tolerance and immunity. Immunity. 2011 Jul 22; 35(1):13-22. doi: 10.1016/j.immuni.2011.07.002 PMID: 21777796
3. Mic FA, Molotkov A, Benbrook DM, Duester G. Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proceedings of the National Academy of Sciences of the United States of America. 2003 Jun 10; 100(12):7135-40. PMID: 12782789
4. Hall JA, Cannons JL, Grainger JR, Dos Santos LM, Hand TW, Naik S, et al. Essential role for retinoic acid in the promotion of CD4(+) T cell effector responses via retinoic acid receptor alpha. Immunity. 2011 Mar 25; 34(3):435-47. doi: 10.1016/j.immuni.2011.03.003 PMID: 21419664
5. Mucida D, Park Y, Kim G, Turovskaya O, Scott I, Kronenberg M, et al. Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid. Science. 2007 Jul 13; 317(5835):256-60. PMID: 17569825
6. Elias KM, Laurence A, Davidson TS, Stephens G, Kanno Y, Shevach EM, et al. Retinoic acid inhibits Th17 polarization and enhances FoxP3 expression through a Stat-3/Stat-5 independent signaling pathway. Blood. 2008 Feb 1; 111(3):1013-20. PMID: 17951529
7. Mora JR, Iwata M, Eksteen B, Song SY, Junt T, Senman B, et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science. 2006 Nov 17; 314(5802):1157-60. PMID: 17110582
8. Stephensen CB, Rasooly R, Jiang X, Ceddia MA, Weaver CT, Chandraratna RA, et al. Vitamin A enhances in vitro Th2 development via retinoid X receptor pathway. Journal of immunology. 2002 May 1; 168(9):4495-503. PMID: 11970994
9. Iwata M, Eshima Y, Kagechika H. Retinoic acids exert direct effects on T cells to suppress Th1 development and enhance Th2 development via retinoic acid receptors. International immunology. 2003 Aug; 15(8):1017-25. PMID: 12882839
10. Chen Q, Ross AC. Vitamin A and immune function: retinoic acid modulates population dynamics in antigen receptor and CD38-stimulated splenic B cells. Proceedings of the National Academy of Sciences of the United States of America. 2005 Oct 4; 102(40):14142-9. PMID: 16093312
11. Chen Q, Mosovsky KL, Ross AC. Retinoic acid and alpha-galactosylceramide differentially regulate B cell activation in vitro and augment antibody production in vivo. Clinical and vaccine immunology: CVI.2011 Jun; 18(6):1015-20. doi: 10.1128/CVI.00004-11 PMID: 21471300
12. Chen Q, Ross AC. Retinoic acid promotes mouse splenic B cell surface IgG expression and maturation stimulated by CD40 and IL-4. Cellular immunology. 2007 Sep; 249(1):37-45. PMID: 18082674
13. Klebanoff CA, Spencer SP, Torabi-Parizi P, Grainger JR, Roychoudhuri R, Ji Y, et al. Retinoic acid controls the homeostasis of pre-cDC-derived splenic and intestinal dendritic cells. The Journal of experimental medicine. 2013 Sep 23; 210(10):1961-76. doi: 10.1084/jem.20122508 PMID: 23999499
14. Tsokos GC. Systemic lupus erythematosus. The New England journal of medicine. 2011 Dec 1; 365 (22):2110-21. doi: 10.1056/NEJMra1100359 PMID: 22129255
15. Sawalha AH, Wang L, Nadig A, Somers EC, McCune WJ, Michigan Lupus C, et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. Journal of autoimmunity. 2012 May; 38(2-3):J216-22. doi: 10.1016/j.jaut.2012.03.004 PMID: 22560840
16. Nacionales DC, Weinstein JS, Yan XJ, Albesiano E, Lee PY, Kelly-Scumpia KM, et al. B cell proliferation, somatic hypermutation, class switch recombination, and autoantibody production in ectopic lymphoid tissue in murine lupus. Journal of immunology. 2009 Apr 1; 182(7):4226-36. doi: 10.4049/ jimmunol.0800771 PMID: 19299721
17. Ching KH, Burbelo PD, Tipton C, Wei C, Petri M, Sanz I, et al. Two major autoantibody clusters in systemic lupus erythematosus. PloS one. 2012; 7(2):e32001. doi: 10.1371/journal.pone.0032001 PMID: 22363785
18. Yung S, Chan TM. Autoantibodies and resident renal cells in the pathogenesis of lupus nephritis: getting to know the unknown. Clinical & developmental immunology. 2012; 2012:139365.
19. Zhou W, Marsh JE, Sacks SH. Intrarenal synthesis of complement. Kidney international. 2001 Apr; 59 (4):1227-35. PMID: 11260382
20. Navarra SV, Guzman RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 2011 Feb 26; 377(9767):721-31. doi: 10.1016/S0140-6736(10)61354-2 PMID: 21296403
21. Merrill JT, Neuwelt CM, Wallace DJ, Shanahan JC, Latinis KM, Oates JC, et al. Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, doubleblind, phase II/III systemic lupus erythematosus evaluation of rituximab trial. Arthritis and rheumatism.Jan; 62(1):222-33. doi: 10.1002/art.27233 PMID: 20039413
22. Illei GG, Austin HA, Crane M, Collins L, Gourley MF, Yarboro CH, et al. Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis. Annals of internal medicine. 2001 Aug 21; 135(4):248-57.PMID: 11511139
23. Crispin JC, Liossis SN, Kis-Toth K, Lieberman LA, Kyttaris VC, Juang YT, et al. Pathogenesis of human systemic lupus erythematosus: recent advances. Trends in molecular medicine. 2010 Feb; 16 (2):47-57. doi: 10.1016/j.molmed.2009.12.005 PMID: 20138006
24. Kinoshita K, Kishimoto K, Shimazu H, Nozaki Y, Sugiyama M, Ikoma S, et al. Successful treatment with retinoids in patients with lupus nephritis. American journal of kidney diseases: the official journal of the National Kidney Foundation. 2010 Feb; 55(2):344-7. doi: 10.1053/j.ajkd.2009.06.012 PMID: 19628316
25. Shima Y, Iwano M, Yoshizaki K, Tanaka T, Kawase I, Nishimoto N. All-trans-retinoic acid inhibits the development of mesangial proliferative glomerulonephritis in interleukin-6 transgenic mice. Nephron Experimental Nephrology. 2005; 100(1):E54-E62. PMID: 15795517
26. Nozaki Y, Yamagata T, Yoo BS, Sugiyama M, Ikoma S, Kinoshita K, et al. The beneficial effects of treatment with all-trans-retinoic acid plus corticosteroid on autoimmune nephritis in NZB/WF1 mice. Clinical and experimental immunology. 2005 Jan; 139(1):74-83. PMID: 15606616
27. Perez de Lema G, Lucio-Cazana FJ, Molina A, Luckow B, Schmid H, de Wit C, et al. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease. Kidney international. 2004 Sep; 66(3):1018-28. PMID: 15327395
28. Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, et al. Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F1 mice. Journal of immunology. 2003 Jun 1; 170 (11):5793-8. PMID: 12759464
29. Lech M, Rommele C, Kulkarni OP, Susanti HE, Migliorini A, Garlanda C, et al. Lack of the long pentraxin PTX3 promotes autoimmune lung disease but not glomerulonephritis in murine systemic lupus erythematosus. PloS one. 2011; 6(5):e20118. doi: 10.1371/journal.pone.0020118 PMID: 21637713
30. Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunological reviews. 2011 May; 241 (1):241-59. doi: 10.1111/j.1600-065X.2011.01017.x PMID: 21488901
31. Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, et al. Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid. The Journal of experimental medicine. 2007 Aug 6; 204(8):1775-85. PMID: 17620362
32. Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, et al. A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. The Journal of experimental medicine. 2007 Aug 6; 204(8):1757-64. PMID: 17620361
33. Uematsu S, Fujimoto K, Jang MH, Yang BG, Jung YJ, Nishiyama M, et al. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nature immunology. 2008 Jul; 9(7):769-76. doi: 10.1038/ni.1622 PMID: 18516037
34. Yamada H, Mizuno S, Ross AC, Sugawara I. Retinoic acid therapy attenuates the severity of tuberculosis while altering lymphocyte and macrophage numbers and cytokine expression in rats infected with Mycobacterium tuberculosis. The Journal of nutrition. 2007 Dec; 137(12):2696-700. PMID: 18029486
35. Drickamer LC. Sexual maturation of female house mice: social inhibition. Developmental psychobiology. 1974 May; 7(3):257-65. PMID: 4857839
36. Rodriguez W, Mold C, Marnell LL, Hutt J, Silverman GJ, Tran D, et al. Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C-reactive protein. Arthritis and rheumatism. 2006 Jan; 54 (1):325-35. PMID: 16385552
37. Liu J, Karypis G, Hippen KL, Vegoe AL, Ruiz P, Gilkeson GS, et al. Genomic view of systemic autoimmunity in MRLlpr mice. Genes and immunity. 2006 Mar; 7(2):156-68. PMID: 16508641
38. Clark AG, Fan Q, Brady GF, Mackin KM, Coffman ED, Weston ML, et al. Regulation of basement mem-brane-reactive B cells in BXSB, (NZBxNZW)F1, NZB, and MRL/lpr lupus mice. Autoimmunity. 2013 May; 46(3):188-204. doi: 10.3109/08916934.2012.746671 PMID: 23157336
39. Ait-Azzouzene D, Kono DH, Gonzalez-Quintial R, McHeyzer-Williams LJ, Lim M, Wickramarachchi D, et al. Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus mice. Journal of immunology. 2010 Jul 15; 185(2):1015-27. doi: 10.4049/jimmunol.1000698 PMID: 20554953
40. Apostolidis SA, Crispin JC, Tsokos GC. IL-17-producing T cells in lupus nephritis. Lupus. 2011 Feb; 20 (2):120-4. doi: 10.1177/0961203310389100 PMID: 21303828
41. Crispin JC, Tsokos GC. IL-17 in systemic lupus erythematosus. Journal of biomedicine & biotechnology. 2010; 2010:943254.
42. Zhang Z, Kyttaris VC, Tsokos GC. The role of IL-23/IL-17 axis in lupus nephritis. Journal of immunology. 2009 Sep 1; 183(5):3160-9. doi: 10.4049/jimmunol.0900385 PMID: 19657089
43. Fehr EM, Spoerl S, Heyder P, Herrmann M, Bekeredjian-Ding I, Blank N, et al. Apoptotic-cell-derived membrane vesicles induce an alternative maturation of human dendritic cells which is disturbed in SLE. Journal of autoimmunity. 2013 Feb; 40:86-95. doi: 10.1016/j.jaut.2012.08.003 PMID: 23031801
44. Teichmann LL, Ols ML, Kashgarian M, Reizis B, Kaplan DH, Shlomchik MJ. Dendritic cells in lupus are not required for activation of T and B cells but promote their expansion, resulting in tissue damage. Immunity. 2010 Dec 14; 33(6):967-78. doi: 10.1016/j.immuni.2010.11.025 PMID: 21167752
45. Young LJ, Wilson NS, Schnorrer P, Proietto A, ten Broeke T, Matsuki Y, et al. Differential MHC class II synthesis and ubiquitination confers distinct antigen-presenting properties on conventional and plasmacytoid dendritic cells. Nature immunology. 2008 Nov; 9(11):1244-52. doi: 10.1038/ni.1665 PMID: 18849989
46. Hellman P, Eriksson H. Early activation markers of human peripheral dendritic cells. Human immunology. 2007 May; 68(5):324-33. PMID: 17462499
47. Greter M, Helft J, Chow A, Hashimoto D, Mortha A, Agudo-Cantero J, et al. GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells. Immunity. 2012 Jun 29; 36(6):1031-46. doi: 10.1016/j.immuni.2012.03.027 PMID: 22749353
48. Plantinga M, Guilliams M, Vanheerswynghels M, Deswarte K, Branco-Madeira F, Toussaint W, et al. Conventional and monocyte-derived CD11b(+) dendritic cells initiate and maintain T helper 2 cell-mediated immunity to house dust mite allergen. Immunity. 2013 Feb 21; 38(2):322-35. doi: 10.1016/j. immuni.2012.10.016 PMID: 23352232
49. Ross AC, Ambalavanan N, Zolfaghari R, Li NQ. Vitamin A combined with retinoic acid increases retinol uptake and lung retinyl ester formation in a synergistic manner in neonatal rats. Journal of lipid research. 2006 Aug; 47(8):1844-51. PMID: 16685080
50. Ross AC, Ambalavanan N. Retinoic acid combined with vitamin A synergizes to increase retinyl ester storage in the lungs of newborn and dexamethasone-treated neonatal rats. Neonatology. 2007; 92 (1):26-32. PMID: 17596734
51. James ML, Ross AC, Bulger A, Philips JB 3rd, Ambalavanan N. Vitamin A and retinoic acid act synergistically to increase lung retinyl esters during normoxia and reduce hyperoxic lung injury in newborn mice. Pediatric research. 2010 Jun; 67(6):591-7. doi: 10.1203/PDR.0b013e3181dbac3d PMID: 20220550
52. Walsh SJ, Algert C, Gregorio DI, Reisine ST, Rothfield NF. Divergent racial trends in mortality from systemic lupus erythematosus. The Journal of rheumatology. 1995 Sep; 22(9):1663-8. PMID: 8523342
53. Rottman JB, Willis CR. Mouse models of systemic lupus erythematosus reveal a complex pathogenesis. Veterinary pathology. 2010 Jul; 47(4):664-76. doi: 10.1177/0300985810370005 PMID: 20448279
54. Kreft B, Yokoyama H, Naito T, Kelley VR. Dysregulated transforming growth factor-beta in neonatal and adult autoimmune MRL-lpr mice. Journal of autoimmunity. 1996 Aug; 9(4):463-72. PMID: 8864821
55. Sobel ES, Brusko TM, Butfiloski EJ, Hou W, Li S, Cuda CM, et al. Defective response of CD4(+) T cells to retinoic acid and TGFbeta in systemic lupus erythematosus. Arthritis research & therapy. 2011; 13 (3):R106.
56. Anolik JH. B cell biology: implications for treatment of systemic lupus erythematosus. Lupus. 2013 Apr; 22(4):342-9. doi: 10.1177/0961203312471576 PMID: 23553777
57. Pau E, Cheung YH, Loh C, Lajoie G, Wither JE. TLR tolerance reduces IFN-alpha production despite plasmacytoid dendritic cell expansion and anti-nuclear antibodies in NZB bicongenic mice. PloS one. 2012; 7(5):e36761. doi: 10.1371/journal.pone.0036761 PMID: 22574220
58. Nowling TK, Gilkeson GS. Mechanisms of tissue injury in lupus nephritis. Arthritis research & therapy. 2011; 13(6):250.
59. Kalaaji M, Mortensen E, Jorgensen L, Olsen R, Rekvig OP. Nephritogenic lupus antibodies recognize glomerular basement membrane-associated chromatin fragments released from apoptotic intraglomerular cells. The American journal of pathology. 2006 Jun; 168(6):1779-92. PMID: 16723695
60. Lech M, Anders HJ. The pathogenesis of lupus nephritis. Journal of the American Society of Nephrology: JASN. 2013 Sep; 24(9):1357-66. doi: 10.1681/ASN.2013010026 PMID: 23929771
61. Degos L, Wang ZY. All trans retinoic acid in acute promyelocytic leukemia. Oncogene. 2001 Oct 29; 20 (49):7140-5. PMID: 11704842
62. Iwata M, Hirakiyama A, Eshima Y, Kagechika H, Kato C, Song SY. Retinoic acid imprints gut-homing specificity on T cells. Immunity. 2004 Oct; 21(4):527-38. PMID: 15485630
63. Hammerschmidt SI, Friedrichsen M, Boelter J, Lyszkiewicz M, Kremmer E, Pabst O, et al. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. The Journal of clinical investigation. 2011 Aug; 121(8):3051-61. doi: 10.1172/JCI44262 PMID: 21737878
64. Villares R, Cadenas V, Lozano M, Almonacid L, Zaballos A, Martinez AC, et al. CCR6 regulates EAE pathogenesis by controlling regulatory CD4+ T-cell recruitment to target tissues. European journal of immunology. 2009 Jun; 39(6):1671-81. doi: 10.1002/eji.200839123 PMID: 19499521
65. Campbell JJ, Haraldsen G, Pan J, Rottman J, Qin S, Ponath P, et al. The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells. Nature. 1999 Aug 19; 400 (6746):776-80. PMID: 10466728
66. Hochheiser K, Heuser C, Krause TA, Teteris S, Ilias A, Weisheit C, et al. Exclusive CX3CR1 dependence of kidney DCs impacts glomerulonephritis progression. The Journal of clinical investigation. 2013 Oct 1; 123(10):4242-54. doi: 10.1172/JCI70143 PMID: 23999431
67. Wright GP, Notley CA, Xue SA, Bendle GM, Holler A, Schumacher TN, et al. Adoptive therapy with redirected primary regulatory T cells results in antigen-specific suppression of arthritis. Proceedings of the National Academy of Sciences of the United States of America. 2009 Nov 10; 106(45):19078-83. doi: 10.1073/pnas.0907396106 PMID: 19884493
68. Viglietta V, Baecher-Allan C, Weiner HL, Hafler DA. Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. The Journal of experimental medicine. 2004 Apr 5; 199(7):971-9. PMID: 15067033
69. Montane J, Bischoff L, Soukhatcheva G, Dai DL, Hardenberg G, Levings MK, et al. Prevention of murine autoimmune diabetes by CCL22-mediated Treg recruitment to the pancreatic islets. The Journal of clinical investigation. 2011 Aug; 121(8):3024-8. doi: 10.1172/JCI43048 PMID: 21737880
70. Iikuni N, Lourenco EV, Hahn BH, La Cava A. Cutting edge: Regulatory T cells directly suppress B cells in systemic lupus erythematosus. Journal of immunology. 2009 Aug 1; 183(3):1518-22. doi: 10.4049/ jimmunol.0901163 PMID: 19570829
71. Kalin JR, Starling ME, Hill DL. Disposition of all-trans-retinoic acid in mice following oral doses. Drug metabolism and disposition: the biological fate of chemicals. 1981 May-Jun; 9(3):196-201. PMID: 6113925
72. Marill J, Idres N, Capron CC, Nguyen E, Chabot GG. Retinoic acid metabolism and mechanism of action: a review. Current drug metabolism. 2003 Feb; 4(1):1-10. PMID: 12570742
73. Adamson PC. All-Trans-Retinoic Acid Pharmacology and Its Impact on the Treatment of Acute Promyelocytic Leukemia. The oncologist. 1996; 1(5):305-14. PMID: 10388008
74. Liu Z, Davidson A. Taming lupus-a new understanding of pathogenesis is leading to clinical advances. Nature medicine. 2012 Jun; 18(6):871-82. doi: 10.1038/nm.2752 PMID: 22674006
75. Perry D, Sang A, Yin Y, Zheng YY, Morel L. Murine models of systemic lupus erythematosus. Journal of biomedicine & biotechnology. 2011; 2011:271694.